SEB Asset Management AB Buys Shares of 129,944 Danaher Corporation $DHR

SEB Asset Management AB purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 129,944 shares of the conglomerate’s stock, valued at approximately $24,637,000.

Other large investors also recently bought and sold shares of the company. Main Street Group LTD bought a new position in shares of Danaher in the first quarter worth about $25,000. JPL Wealth Management LLC purchased a new position in Danaher in the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC bought a new position in Danaher in the 4th quarter worth about $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the fourth quarter worth approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of a number of recent research reports. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Guggenheim decreased their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Royal Bank Of Canada started coverage on Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price for the company. Finally, Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $231.64.

Danaher Stock Performance

NYSE:DHR opened at $203.65 on Monday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a fifty day moving average of $183.27 and a two-hundred day moving average of $198.25. The stock has a market capitalization of $144.14 billion, a PE ratio of 39.39, a P/E/G ratio of 2.51 and a beta of 0.79.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.88 EPS. As a group, research analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.